USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
14 Mar 2023 | 03:45 PM GMT

Patient Engagement Metrics in Digital Health for Oncology

Anchored by:

Kate Wolin, ScD, FACSM, FSBM
Partner
PACE HEALTHCARE CAPITAL

Participants:

Kate Wolin, ScD, FACSM, FSBM PartnerPACE Healthcare Capital
Kate Wolin, ScD, FACSM, FSBM
PartnerPACE Healthcare Capital
Anish Shindore Founder & Managing PartnerGSD Health
Anish Shindore
Founder & Managing PartnerGSD Health
Gregoire Guillet Chief Business and Value OfficerWeHealth Digital Medicine
Gregoire Guillet
Chief Business and Value OfficerWeHealth Digital Medicine
Ivan Jurisic Head of ProductPatients Influence
Ivan Jurisic
Head of ProductPatients Influence
KW
Kate Wolin Principal/AdvisorCircea
KW
Kate Wolin
Principal/AdvisorCircea
Krishna Moorthy Senior Lecturer, Consultant SurgeonImperial College London
Krishna Moorthy
Senior Lecturer, Consultant SurgeonImperial College London
Mark Duman Managing Partner/Chief Patient OfficerMD Healthcare Consultants
Mark Duman
Managing Partner/Chief Patient OfficerMD Healthcare Consultants
Tahir Hussain Global Pharma Business Dev. Digital HealthBiofourmis
Tahir Hussain
Global Pharma Business Dev. Digital HealthBiofourmis

About this Meeting

Small, intimate and participant-led discussions tackling digital health challenges. Spaces are limited to 8 - 12 people, allowing you to focus on quality in-depth conversations.

Measuring patient engagement with digital health solutions is crucial to ensure the digital intervention is impactful and helps improve patient outcomes. These metrics are key for digital health companies, not only to keep improving and personalising their solutions, but also to show value when talking to payers for reimbursement, pharma and medtech for partnerships, or investors for funding. 

All these stakeholders keep asking for general measures of patient engagement, but what does great engagement look like in oncology? How to meet the expectations? Join your peers in this discussion to dive deep into: 

  • Current engagement metrics requirements by payers, pharma, and investors. What patient engagement metrics are the different stakeholders expecting to see?
  • What does ‘great patient engagement’ look like in digital health solutions for oncology? Every patient and every digital health product is different (e.g. digital solutions for episodic support vs. ongoing), so how can we define what ‘great patient engagement’ is? How does the definition change depending on the cancer chronicity, sociodemographic group, gender, or other?  
  • How can the industry define patient engagement standards? The healthcare industry is used to working with standards to understand what is good and what is not. How can we create standards that help the industry distinguish what is good and what is not for digital health in oncology?
  • Showing patient engagement beyond pilots. Patient engagement metrics can be initially gathered in pilots or studies, but performance in the real market is different. What are the best real-world data points to demonstrate successful patient utilisation? 
  • Challenges in using patient data. What are the challenges when tracking patient engagement metrics in oncology (e.g data collection, data standardisation, data privacy & security, data interpretation, limited resources, etc.)? How to make sure the data will be accurate, reliable and meaningful? 
We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.